Keywords: india, raises, antifungal, parkinson, drug, prices, national
India raises antifungal, Parkinson's drug prices
Article | 05 August 2002
India's National Pharmaceutical Pricing Authority has increased thenon-ceiling price of the Parkinson's drug Madopar (levodopa and benzerazide), manufactured by Nicholas ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
